Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
1987-11-2
|
pubmed:abstractText |
Thirty patients undergoing allogeneic bone marrow transplantation (BMT) for hematologic malignancies received ciclosporin A (CS-A) as prophylaxis of graft-versus-host disease (GVHD). CS-A trough levels were determined in whole blood by radioimmunoassay (RIA); results were not used to adjust the CS-A dosage. Neither the dose of CS-A administered nor the CS-A concentration and fluctuation of blood levels during the first 15 days after BMT correlated with acute GVHD. Conversely in the 13 patients with acute GVHD, CS-A concentrations in the 10 days prior to the onset of the disease were increasingly lower with increasing severity of GVHD. Moreover, patients without GVHD had higher CS-A concentrations in a matched period of time. Upon withdrawal of CS-A treatment, 7 patients developed GVHD. There was no possibility to predict who would do so, but the analysis of CS-A disappearance profiles indicates that effective CS-A concentrations might be lower during long-term treatment than the concentrations required early after transplant. Despite these relationships, CS-A concentration is of little predictive value in the individual patient because of the considerable overlap among patients.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
0001-5792
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
78
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
N
|
pubmed:pagination |
6-12
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:3116813-Acute Disease,
pubmed-meshheading:3116813-Adolescent,
pubmed-meshheading:3116813-Adult,
pubmed-meshheading:3116813-Bone Marrow Transplantation,
pubmed-meshheading:3116813-Child,
pubmed-meshheading:3116813-Child, Preschool,
pubmed-meshheading:3116813-Cyclosporins,
pubmed-meshheading:3116813-Female,
pubmed-meshheading:3116813-Graft vs Host Disease,
pubmed-meshheading:3116813-Humans,
pubmed-meshheading:3116813-Male,
pubmed-meshheading:3116813-Middle Aged,
pubmed-meshheading:3116813-Osmolar Concentration
|
pubmed:year |
1987
|
pubmed:articleTitle |
Ciclosporin A: correlation of blood levels with acute graft-versus-host disease after bone marrow transplantation.
|
pubmed:affiliation |
Institute of Hematology Lorenzo e Ariosto Seragnoli, St. Orsola University Hospital, Bologna, Italy.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|